The United States Histone Deacetylase Inhibitors Market is further supported by a robust biotechnology ecosystem, strategic collaborations between research institutions and drug developers, and ongoing efforts to expand the therapeutic applications of HDAC inhibitors. Growing prevalence of cancer and increasing interest in targeted and personalized therapies are encouraging demand for...